Rallybio Announces In-Licensing of Potential First-In-Class Preclinical Antibody Candidate from Sanofi

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/30/2026

1. META
2. MSFT
3. FTNT
4. QCOM
5. ARM
6. SBUX
7. CVNA
8. TENB
9. CMG
10. EQIX

Go back to Rallybio Announces In-Licensing of Potential First-In-Class Preclinical Antibody Candidate from Sanofi
(NASDAQ: RLYB) Delayed: 15.90 -0.06 (0.38%)
Previous Close $15.96    52 Week High $ 
Open $15.91    52 Week Low $ 
Day High $16.28    P/E N/A 
Day Low $15.90    EPS $ 
Volume 6,110